NEUROPATHY & LYMPHOEDEMA IN ONCOLOGY PATIENTS

Two unmissable webinars

Dear all,
Here we are with a new Series of webinars! The first two appointments will be presented by a team of prestigious customers.

Since several years, we support Hasselt University Limburg Oncologic Center (LOC), as well as the two largest hospitals in Limburg, Jessa Ziekenhuis and Ziekenhuis Oost-Limburg, part of the Limburg Clinical Research Center (LCRC).

In recent times, their research teams have conducted and published several clinical studies, presented to World Oncology Association Congresses about the beneficial findings of MLS® Laser Therapy in treating oncology patients affected by radio-dermatitis or in order to prevent it.

They are now working on new clinical studies, where the spotlight is on neuropathy and lymphoedema in oncology patients.
The clinical results gathered during these studies are so interesting that in 2019 the research team, together with academics and clinicians, launched LOwLIght, an institution that combines scientific knowledge and clinical expertise with the aim of enhancing the patients quality of life. Check it out: www.lowlight.info.

We are now offering to our community the chance to experience first-hand the latest development in such delicate yet interesting and common topic.

Photobiomodulation for the prevention and management of chemotherapy-induced peripheral neuropathy


01:00 - 02:00 PM (CET)
February 2023
21
REGISTER NOW

Speaker: Marithé Claes

 

She obtained her BSc and MSc in Biomedical Sciences at Hasselt University, Belgium. Since September 2021 she is doing a PhD focusing on the use of PBM for the prevention and management of chemotherapy-induced alopecia, neuropathy and radiotherapy-induced gynaecological complications.

Photobiomodulation for the management of cancer-related lymphoedema


01:00 - 02:00 PM (CET)
March 2023
14
REGISTER NOW

Speaker: Jolien Robijns


She obtained her BSc and MSc in Biomedical Sciences at Hasselt University, Belgium. Her Ph.D. project's main topic was applying PBM to prevent and manage acute radiodermatitis in cancer patients. She is now investigating the beneficial effects of PBM for multiple indications in supportive cancer care.

Free registration, limited seats. By registering for one of this two events, you will be registering for both sessions.
We recommend you share this invitation within your loyal customers and really interested potential customers.

ASA Staff
webinar@asalaser.com
FRIEND ON FACEBOOK
Instagram
VISIT OUR PAGE
Copyright © 2023, All rights reserved.
ASA srl | Via Galileo Galilei, 23 - 36057 Arcugnano (Vicenza) Italia
T. +39 0444 289200 | www.asalaser.com